LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA) concerning possible violations of federal securities laws between August 5, 2015 and October 21, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the April 3, 2017 lead plaintiff motion deadline.
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the complaint, during the Class Period, DaVita made false and/or misleading statements and/or failed to disclose: that the Company purposefully steered patients into unnecessary insurance plans in order to maximize profits; that DaVita was using the American Kidney Fund as a vehicle to facilitate these improper practices; that the Company’s revenues and profits were illegally obtained; that DaVita lacked effective internal controls over financial reporting; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this news reached the public, the stock price of DaVita fell, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.